Title:
COMBINATION THERAPIES FOR B-CELL LYMPHOMAS COMPRISING ADMINISTRATION OF ANTI-CD20 ANTIBODY
Document Type and Number:
Japanese Patent JP2019065023
Kind Code:
A
Abstract:
To provide combination therapies for B-cell lymphomas which use treatment using anti-CD20 antibodies in combination with cytokines or with a radiotherapy, myeloablative therapy or chemotherapy.SOLUTION: A method for treating a relapsed B-cell lymphoma comprises administering a therapeutically effective amount of an anti-CD20 antibody to a patient having the relapsed B-cell lymphoma.SELECTED DRAWING: None
Inventors:
GRILLO-LOPEZ ANTONIO
Application Number:
JP2018233050A
Publication Date:
April 25, 2019
Filing Date:
December 13, 2018
Export Citation:
Assignee:
BIOGEN NV
International Classes:
A61K38/21; A61K31/4745; A61K39/395; A61K31/475; A61K31/569; A61K31/573; A61K31/675; A61K31/704; A61K38/00; A61K38/19; A61K38/20; A61K51/00; A61K51/10; A61L27/36; A61L27/38; A61P35/00; A61P35/04; A61P43/00; C02F1/00; C07K16/00; C07K16/28
Attorney, Agent or Firm:
Asamura patent office